#Open journalism No news is bad news

Your contributions will help us continue to deliver the stories that are important to you

Support The Journal
Dublin: 9°C Tuesday 1 December 2020
Advertisement

€1 million export deal for Dragon's Den reject

Mullingar native lands export deal despite being turned down by Dragons.

MedColl chief executive Roz Martin
MedColl chief executive Roz Martin

AN IRISH BIOTECHNOLOGY company that failed to make the grade on Dragon’s Den has taken the wraps off a €1 million Middle Eastern distribution deal.

Dublin-based MedColl, which makes anti-aging supplements, signed the deal with Il Ittihad Drugs despite being turned down by dragons Gavin Duffy and Ramona Nichols.

Chief executive Roz Martin said that she had managed to refine and develop her export offering in only 4 and a half months. She was assisted by Enterprise Ireland and export accelerators Associated Marketing.

Martin said that she was “a little disappointed” not to receive funding from the Dragons, but continued:

Their decision will not hold us back as we are currently working closely with Enterprise Ireland in identifying venture capitalists who have the ability and funding to help us expand the company and grow our global exports.

MedColl is specifically designed for women in their 30s and 40s, as well as post-menopausal women.

Value of Irish food and drink exports nearly €10 billion in 2013>

Guess how much Kerrygold was sold around the world last year>

#Open journalism No news is bad news Support The Journal

Your contributions will help us continue to deliver the stories that are important to you

Support us now

About the author:

Jack Horgan-Jones

Read next:

COMMENTS (49)